Medicine and Dentistry
Patient
100%
Mitoxantrone
42%
Anticarcinogen
28%
Phase I Trials
28%
Leukopenia
28%
Clinical Trial
28%
Spontaneous Remission
14%
Toxicity
14%
Malignant Neoplasm
14%
Neutropenia
14%
Nausea and Vomiting
14%
Thrombocytopenia
14%
Mucositis
14%
Stomach Carcinoma
14%
Alopecia Mucinosa
14%
Drug
14%
Chemotherapeutic Agent
14%
Hypopharynx
14%
Anthraquinone
14%
Therapeutic Procedure
14%
Bone Marrow
14%
Inpatient
14%
Rectum
14%
Pharmacology, Toxicology and Pharmaceutical Science
Mitoxantrone
42%
Anticarcinogen
28%
Leukopenia
28%
Squamous Cell Carcinoma
14%
Toxicity
14%
Neutropenia
14%
Remission
14%
Nausea and Vomiting
14%
Mucosa Inflammation
14%
Thrombocytopenia
14%
Malignant Neoplasm
14%
Alopecia
14%
Drug
14%
Stomach Carcinoma
14%
Anthraquinone
14%